Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Mar 2017 for Mylan II B.V., €1.7B.
Filing timeline
BuySaleLaboratories Abbott
Insider track record
Disclosed buys
3
Disclosed sells
1
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Laboratories Abbott: trading record in brief
This profile gathers the share dealings of Laboratories Abbott across 5 companies, led by Mylan II B.V., Advanced Medical Optics Inc and Facet Biotech Corp. Over a trading history stretching from 25 February 2009 to 23 March 2017, the count stands at 9 filings.
On the open market, the record shows 3 purchases worth €3.0B and 1 sale worth €1.7B. Taken together, the purchases exceed the sales by €1.3B. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. 2017 to date brings no purchases and 1 sale.
In size, the median ticket on the buying side is €975.1M.
On 24 March 2017 came the latest disclosure, an open-market sale for €1.7B in Mylan II B.V. The last purchase on record was published on 21 April 2010, which is 6,029 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Laboratories Abbott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
44,000,000 shares@ US$41.60100.0% of flowOrdinary Shares, nominal value Euro 0.01 per shareSEC:0001104659-17-019006:0
5,250,000 shares@ US$56.8912Ordinary Shares, nominal value Euro 0.01 per shareSEC:0001104659-15-026765:0
35,000,000 shares@ US$56.8912Ordinary Shares, nominal value euro 0.01 per shareSEC:0001104659-15-025547:0
101 shares0Common stock, $0.01 par valueSEC:0001179110-12-017658:0
2,243,649 sharesCommon StockSEC:0001104659-10-062171:0
62,652,055 shares@ US$27.00Common StockSEC:0001104659-10-021021:0
Canonical exit: 19 Jul 2010 (T+90)
5,980,034 shares@ US$27.00Common StockSEC:0001104659-10-021021:1
44,720,768 shares@ US$22.00Common StockSEC:0001104659-09-013218:0
Canonical exit: 27 May 2009 (T+90)
56,395,914 shares@ US$22.00Common StockSEC:0001104659-09-012102:0
Canonical exit: 26 May 2009 (T+90)
9 of 9 declarations
